# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!


B-Cell Lymphomas

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 2061-2070 of 2224 results.
Rasburicase and Allopurinol in Treating Patients With Hematologic Malignancies
Status: Terminated
Last Changed: Jan 09, 2018
First Received: Mar 27, 2012
Disease(s): Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Blastic Phase Chronic Myelogenous Leukemia, Contiguous Stage II Adult Burkitt Lymphoma, de Novo Myelodysplastic Syndromes, Noncontiguous Stage II Adult Burkitt Lymphoma, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Burkitt Lymphoma, Stage I Adult Burkitt Lymphoma, Stage III Adult Burkitt Lymphoma, Stage IV Adult Burkitt Lymphoma, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Adult Acute Myeloid Leukemia
Intervention(s): rasburicase, allopurinol
Locations: Roswell Park Cancer Institute, Buffalo, New York, United States
Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Status: Recruiting
Last Changed: Jul 02, 2020
First Received: Dec 09, 2009
Disease(s): Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia in Remission, Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With Inv(3) (q21.3;q26.2); GATA2, MECOM, Acute Myeloid Leukemia With Multilineage Dysplasia, Acute Myeloid Leukemia With t(6;9) (p23;q34.1); DEK-NUP214, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Complete Remission, B Acute Lymphoblastic Leukemia With t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1), B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Burkitt Lymphoma, Childhood Acute Lymphoblastic Leukemia in Complete Remission, DS Stage II Plasma Cell Myeloma, DS Stage III Plasma Cell Myeloma, Myelodysplastic Syndrome, Recurrent Anaplastic Large Cell Lymphoma, Blasts Under 5 Percent of Bone Marrow Nucleated Cells, Recurrent Follicular Lymphoma, Recurrent Hodgkin Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma, Secondary Acute Myeloid Leukemia, T Lymphoblastic Lymphoma, Hematopoietic Cell Transplant Recipient
Intervention(s): Cyclophosphamide, Filgrastim, Fludarabine Phosphate, Laboratory Biomarker Analysis, Mycophenolate Mofetil, Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation, Peripheral Blood Stem Cell Transplantation, Tacrolimus, Total-Body Irradiation, Fludarabine
Locations: VA Puget Sound Health Care System, Seattle, Washington, United States
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Topotecan Hydrochloride in Treating Children With Meningeal Cancer That Has Not Responded to Previous Treatment
Status: Completed
Last Changed: Feb 21, 2013
First Received: Jan 27, 2003
Disease(s): AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell Lymphoma, AIDS-related Immunoblastic Large Cell Lymphoma, AIDS-related Lymphoblastic Lymphoma, AIDS-related Peripheral/Systemic Lymphoma, AIDS-related Primary CNS Lymphoma, AIDS-related Small Noncleaved Cell Lymphoma, Childhood Diffuse Large Cell Lymphoma, Childhood Immunoblastic Large Cell Lymphoma, HIV-associated Hodgkin Lymphoma, Leptomeningeal Metastases, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Childhood Large Cell Lymphoma, Recurrent Childhood Lymphoblastic Lymphoma, Recurrent Childhood Medulloblastoma, Recurrent Childhood Small Noncleaved Cell Lymphoma, Recurrent/Refractory Childhood Hodgkin Lymphoma, Unspecified Childhood Solid Tumor, Protocol Specific
Intervention(s): topotecan hydrochloride, laboratory biomarker analysis
Locations: Children's Oncology Group, Arcadia, California, United States
A Study of Patients With AIDS Syndrome
Status: Completed
Last Changed: Sep 12, 2008
First Received: Aug 31, 2001
Disease(s): Sarcoma, Kaposi, Lymphoma, Non-Hodgkin, HIV Infections, Lymphoma, AIDS-Related
Locations: Willow Clinic, Menlo Park, California, United States
San Francisco Gen Hosp, San Francisco, California, United States
Marin County Specialty Clinic, San Rafael, California, United States
San Mateo AIDS Program / Stanford Univ, Stanford, California, United States
Stanford Univ Med Ctr, Stanford, California, United States
... and 19 other locations.
Safety and Efficacy of RAD001 in Patients With Mantle Cell Lymphoma Who Are Refractory or Intolerant to Velcade® Therapy.
Status: Completed
Last Changed: Oct 22, 2020
First Received: Jun 20, 2008
Disease(s): Lymphoma, Mantle- Cell
Intervention(s): RAD001
Locations: Mayo Clinic - Arizona Mayo Clinic - Scottsdale, Multiple Locations, Arizona, United States
Highlands Oncology Group DeptofHighlandsOncologyGrp(2), Fayetteville, Arkansas, United States
Bay Area Cancer Research Dept.ofBayAreaCancerResearch, Concord, California, United States
City of Hope National Medical Center Dept.ofCityofHopeMedicalCtr(1), Duarte, California, United States
UCLA/ University of California Los Angeles Dept.of Hem/Oncology, Los Angeles, California, United States
... and 27 other locations.
Specimen Collections From Patients With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
Status: Recruiting
Last Changed: Oct 06, 2020
First Received: Nov 23, 2000
Disease(s): HIV, Kaposi's Sarcoma, Lymphomas, Multicentric Castleman's Disease, Primary Effusion Lymphoma
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Treatment and Natural History Study of Lymphomatoid Granulomatosis
Status: Recruiting
Last Changed: Sep 17, 2020
First Received: Nov 04, 1999
Disease(s): Lymphomatoid Granulomatosis, Granulomatosis, Lymphomatoid, Non-Hodgkins Lymphoma, Lymphoproliferative Disorder
Intervention(s): Interferon, Rituxan and EPOCH
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma
Status: Completed
Last Changed: Jul 08, 2015
First Received: Dec 19, 2006
Disease(s): Solid Tumor, Lymphoma
Intervention(s): oral belinostat
Locations: Yale New Haven Hospital, New Haven, Connecticut, United States
Columbia University - Herbert Irving Cancer Center, New York, New York, United States
New York University Cancer Institute, New York, New York, United States
M.D. Anderson Cancer Center, Houston, Texas, United States
Research Facility, Copenhagen, Denmark
... and 2 other locations.
Safety Study of Different Doses of hA20 (Veltuzumab) in CD20+ Non-Hodgkin's Lymphoma
Status: Completed
Last Changed: Feb 06, 2012
First Received: Jan 17, 2008
Disease(s): Non-Hodgkin's Lymphoma, Lymphoma, Diffuse, Lymphoma, Diffuse, Mixed Lymphocytic-Histiocytic
Intervention(s): veltuzumab
Locations: Service Des Maladies Du Sang, Lille, Cedex, France
Centre hospitalier Lyon, Lyon, Pierre Benite Cedex, France
University of Leicester, Leicester, United Kingdom
Safety and Efficacy of CD19-Targeted CAR-T Therapy for Relapsed/Refractory CD19+ B Cell Leukemia and Lymphoma
Status: Recruiting
Last Changed: Feb 17, 2020
First Received: Feb 17, 2020
Disease(s): Leukemia, Lymphoma, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell
Intervention(s): CD19 CAR-T cells
Locations: Chongqing University Cancer Hospital, Chongqing, Chongqing, China